Literature DB >> 15479838

Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies.

Lakshmanan Ganesh1, Kwanyee Leung, Karin Loré, Reuven Levin, Amos Panet, Owen Schwartz, Richard A Koup, Gary J Nabel.   

Abstract

The tropism of human immunodeficiency virus type 1 for chemokine receptors plays an important role in the transmission of AIDS. Although CXCR4-tropic virus is more cytopathic for T cells, CCR5-tropic strains are transmitted more frequently in humans for reasons that are not understood. Phenotypically immature myeloid dendritic cells (mDCs) are preferentially infected by CCR5-tropic virus, in contrast to mature mDCs, which are not susceptible to infection but instead internalize virus into a protected intracellular compartment and enhance the infection of T cells. Here, we define a mechanism to explain preferential transmission of CCR5-tropic viruses based on their interaction with mDCs and sensitivity to neutralizing antibodies. Infected immature mDCs differentiated normally and were found to enhance CCR5-tropic but not CXCR4-tropic virus infection of T cells even in the continuous presence of neutralizing antibodies. Infectious synapses also formed normally in the presence of such antibodies. Infection of immature mDCs by CCR5-tropic virus can therefore establish a pool of infected cells that can efficiently transfer virus at the same time that they protect virus from antibody neutralization. This property of DCs may enhance infection, contribute to immune evasion, and could provide a selective advantage for CCR5-tropic virus transmission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479838      PMCID: PMC523246          DOI: 10.1128/JVI.78.21.11980-11987.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

Authors:  T B Geijtenbeek; D S Kwon; R Torensma; S J van Vliet; G C van Duijnhoven; J Middel; I L Cornelissen; H S Nottet; V N KewalRamani; D R Littman; C G Figdor; Y van Kooyk
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

Review 2.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

3.  HIV gp120 receptors on human dendritic cells.

Authors:  S G Turville; J Arthos; K M Donald; G Lynch; H Naif; G Clark; D Hart; A L Cunningham
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

4.  DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection.

Authors:  Douglas S Kwon; Glenn Gregorio; Natacha Bitton; Wayne A Hendrickson; Dan R Littman
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

5.  HIV-1 infection of placental cord blood monocyte-derived dendritic cells.

Authors:  R M Folcik; J D Merrill; Y Li; C J Guo; S D Douglas; S E Starr; W Z Ho
Journal:  J Hematother Stem Cell Res       Date:  2001-10

6.  Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.

Authors:  H Donaghy; A Pozniak; B Gazzard; N Qazi; J Gilmour; F Gotch; S Patterson
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

7.  Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission.

Authors:  Li Wu; Thomas D Martin; Rosemay Vazeux; Derya Unutmaz; Vineet N KewalRamani
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.

Authors:  John R Mascola; Mark K Louder; Christine Winter; Ranjani Prabhakara; Stephen C De Rosa; Daniel C Douek; Brenna J Hill; Dana Gabuzda; Mario Roederer
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Authors:  M B Zwick; A F Labrijn; M Wang; C Spenlehauer; E O Saphire; J M Binley; J P Moore; G Stiegler; H Katinger; D R Burton; P W Parren
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.

Authors:  M Pope; S Gezelter; N Gallo; L Hoffman; R M Steinman
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  78 in total

Review 1.  Dangerous liaisons at the virological synapse.

Authors:  Vincent Piguet; Quentin Sattentau
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

2.  In vitro activities of candidate microbicides against cell-associated HIV.

Authors:  Philippe Selhorst; Katrijn Grupping; Thomas Bourlet; Olivier Delézay; Kevin K Ariën; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

3.  Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.

Authors:  Daniela Tudor; Huifeng Yu; Julien Maupetit; Anne-Sophie Drillet; Tahar Bouceba; Isabelle Schwartz-Cornil; Lucia Lopalco; Pierre Tuffery; Morgane Bomsel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-20       Impact factor: 11.205

4.  Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells.

Authors:  Amichai Yavlovich; Mathias Viard; Ming Zhou; Timothy D Veenstra; Ji Ming Wang; Wanghua Gong; Eliahu Heldman; Robert Blumenthal; Yossef Raviv
Journal:  Blood       Date:  2012-07-02       Impact factor: 22.113

5.  3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells.

Authors:  Richard L Felts; Kedar Narayan; Jacob D Estes; Dan Shi; Charles M Trubey; Jing Fu; Lisa M Hartnell; Gordon T Ruthel; Douglas K Schneider; Kunio Nagashima; Julian W Bess; Sina Bavari; Bradley C Lowekamp; Donald Bliss; Jeffrey D Lifson; Sriram Subramaniam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

6.  HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.

Authors:  Thijs van Montfort; Dirk Eggink; Maikel Boot; Michael Tuen; Catarina E Hioe; Ben Berkhout; Rogier W Sanders
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

7.  p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells.

Authors:  Karlhans Fru Che; Esaki Muthu Shankar; Sundaram Muthu; Sasan Zandi; Mikael Sigvardsson; Jorma Hinkula; Davorka Messmer; Marie Larsson
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

8.  Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV.

Authors:  Ali Danesh; Yanqin Ren; R Brad Jones
Journal:  Curr Opin HIV AIDS       Date:  2020-09       Impact factor: 4.283

Review 9.  HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy.

Authors:  Luis M Agosto; Pradeep D Uchil; Walther Mothes
Journal:  Trends Microbiol       Date:  2015-03-09       Impact factor: 17.079

10.  Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.

Authors:  Po-Jen Yen; Alon Herschhorn; Hillel Haim; Ignacio Salas; Christopher Gu; Joseph Sodroski; Dana Gabuzda
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.